Search By Initial

Cas Index 2

• 2366152-15-8 | RPT193 (Catalog# : 20526)
• 2192215-81-7 | Ritlecitinib tosylate (Catalog# : 20452)Ritlecitinib, also known as PF-06651600, is a potent and selective JAK3 inhibitor. PF
• 2171386-10-8 | RK-287107 (Catalog# : 2071520)RK-287107 is a potent TNKS/TNKS2 inhibitor (IC50 = 14.4 nM) with >7000-fold select
• 2381037-82-5 | RBN-2397 (Catalog# : 207101)
• 2161337-98-8 | (2R,6S)-tert-butyl 4-(4-aminobenzoyl)-2,6-dimethylpiperazine-1-carboxylate (Catalog# : 2062334)
• 243984-11-4 | Resatorvid (Catalog# : 206102)Resatorvid, also known as TAK-242, is a cell-permeable inhibitor of TLR4 signaling, b
• 2262452-06-0 | RU320521 (Catalog# : 204503)RU320521, also known as RU521; RU.521 is a potent and selective inhibitor of cGAS, in
• 2086689-88-3 | (R)-tert-butyl 2-(2-ethynyl-2-methylpyrrolidin-1-yl)acetate (Catalog# : 580586)(R)-tert-butyl 2-(2-ethynyl-2-methylpyrrolidin-1-yl)acetate, CAS 2086689-88-3, is a v
• 2072057-17-9 | RG7834 (Catalog# : 19355)RG7834，also known as RO7020322, is a novel oral HBV viral gene expression inhibitor
• 252889-88-6 | RWJ-56110 (Catalog# : 19353)RWJ-56110 is a selective protease-activated receptor-1 (PAR1) antagonist. It blocks t
• 259188-38-0 | Rebimastat (Catalog# : 192254)Rebimastat, also known as BMS275291, is a sulfhydryl-based second-generation matrix m
• 2172651-73-7 | RMC-4550 (Catalog# : 186251)RMC-4550 is a potent and selective SHP2 inhibitor.
• 2133832-83-2 | R-IMPP (Catalog# : 18413)R-IMPP is an inhibitor of PCSK9 translation.
• 2003234-63-5 | R-GNE-140 (Catalog# : 18432)R-GNE-140 a novel potent lactate dehydrogenase (LDHA) inhibitor with IC50 3nM for LDH
• 2097334-19-3 | (2R,14R)-4-((R)-1-((R)-4-benzyl-2-oxooxazolidin-3-yl)-3-(tert-butoxycarbonyl)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate (Catalog# : 183217)(2R,14R)-4-((R)-1-((R)-4-benzyl-2-oxooxazolidin-3-yl)-3-(tert-butoxycarbonyl)-1-oxopr
• 2097334-18-2 | (R)-4-(2-(4-benzyl-2-oxooxazolidin-3-yl)-2-oxoethyl)benzyl 2,4-dimethylbenzoate (Catalog# : 183216)(R)-4-(2-(4-benzyl-2-oxooxazolidin-3-yl)-2-oxoethyl)benzyl 2,4-dimethylbenzoate is a
• 269730-03-2 | RPI-1 (Catalog# : 17030301)RPI-1 is an ATP-dependent RET kinase inhibitor. Oral treatment with RPI-1 caused grow
• 283173-50-2 | Rucaparib (Catalog# : 123005)Rucaparib is an inhibitor of PARP with Ki of 1.4 nM for PARP1, also showing binding a
• 27298-99-3 | (1R)-1-(4-chlorophenyl)ethanamine (Catalog# : 91124)Coming soon!
• 239105-47-6 | (1R)-1-(4-methylphenyl)propan-1-amine,hydrochloride (Catalog# : 91106)Coming soon!
• 23844-66-8 | (1R)-2-methyl-1-phenylpropan-1-amine (Catalog# : 91103)Coming soon!
• 278788-60-6 | (2R)-1-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylic acid (Catalog# : 81724)Coming soon!
• 213261-59-7 | RITA (Catalog# : 52526)RITA(NSC 652287) induced both DNA-protein and DNA-DNA cross-links with no detectable
• 2097938-74-2 | Stafib-2 (Catalog# : 24142)Stafib-2 is a potent and selctive inhibitor of the transcription factor STAT5b, with
• 2589531-76-8 | Saruparib (Catalog# : 24100)Saruparib, also known as AZD5305 is a potent, selective and oral active PARP inhibito
• 2274723-90-7 | SPG-302 (Catalog# : 24065)Phenylbenzothiazole-PEG4-OH (compound 1) can treat spinal cord injury and promote spi
• 2226636-04-8 | soquelitinib (Catalog# : 20671)
• 2222138-31-8 (HCl) | Sotuletinib HCl (Catalog# : 20663)Sotuletinib, also known as BLZ945, is a potent and selective CSF-1R kinase inhibitor.
• 2383086-06-2 | Sonrotoclax (BGB-11417) (Catalog# : 20650)Sonrotoclax is an antineoplastic.
• 2546091-70-5 | SOP1812 (QN-302) (Catalog# : 20639)QN-302 is a G-quadruplex (G4)-selective transcription inhibitor.